Technology

Jennifer Doudna, Co-Founder of Scribe Therapeutics, Receives 2020 Nobel Prize in Chemistry

[ad_1] ALAMEDA, California – (BUSINESS WIRE) – Scribe Therapeutics Inc. co-founder Jennifer Doudna, Ph.D., received the 2020 Nobel Prize in Chemistry along with collaborator Emmanuelle Charpentier, Ph.D., for her discovery of CRISPR, the genome editing technology that It has transformed modern science and biomedicine. The two scientists are the first …

Read More »